Gottenberg, J., Dörner, T., Bootsma, H., Devauchelle‐Pensec, V., Bowman, S. J., Mariette, X., . . . Gordon, C. (2018). Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials. Arthritis Rheumatol.
Citação norma ChicagoGottenberg, Jacques‐Eric, et al. "Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials." Arthritis Rheumatol 2018.
MLA citiranjeGottenberg, Jacques‐Eric, et al. "Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials." Arthritis Rheumatol 2018.